Aziz Z - Search Results

1

Allopurinol-induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia.

Panickar R, Wo WK, Ali NM, Tang MM, Ramanathan GRL, Kamarulzaman A, Aziz Z. Panickar R, et al. Among authors: aziz z. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1254-1262. doi: 10.1002/pds.5033. Pharmacoepidemiol Drug Saf. 2020. PMID: 33084196

2

Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.

Aziz Z, Siang TC, Badarudin NS. Aziz Z, et al. Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):223-8. doi: 10.1002/pds.1313. Pharmacoepidemiol Drug Saf. 2007. PMID: 16947117

3

Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.

Hariraj V, Aziz Z. Hariraj V, et al. Among authors: aziz z. Ther Innov Regul Sci. 2018 Nov;52(6):757-763. doi: 10.1177/2168479017745025. Epub 2018 Mar 1. Ther Innov Regul Sci. 2018. PMID: 29714567

4

Complementary and alternative medicine: Pharmacovigilance in Malaysia and predictors of serious adverse reactions.

Shaikh Abdul Rahman S, Aziz Z. Shaikh Abdul Rahman S, et al. Among authors: aziz z. J Clin Pharm Ther. 2020 Oct;45(5):946-958. doi: 10.1111/jcpt.13106. Epub 2020 Jan 11. J Clin Pharm Ther. 2020. PMID: 31925959

5

Biosimilars in Malaysia: Regulatory Framework, Approved Products, and Adverse Effects.

Mohd Sani N, Aziz Z, Kamarulzaman A. Mohd Sani N, et al. Among authors: aziz z. Ther Innov Regul Sci. 2021 May;55(3):490-502. doi: 10.1007/s43441-020-00243-y. Epub 2020 Nov 24. Ther Innov Regul Sci. 2021. PMID: 33231863 Review.

6

Methodological quality of guidelines for the management of opioid use disorder: A systematic review.

Watan Pal A, Aziz Z, Kamarulzaman A. Watan Pal A, et al. Among authors: aziz z. J Clin Pharm Ther. 2021 Dec;46(6):1531-1548. doi: 10.1111/jcpt.13449. Epub 2021 Jun 22. J Clin Pharm Ther. 2021. PMID: 34159618

7

Pharmacists' Perspectives of Biosimilars: A Systematic Review.

Mohd Sani N, Aziz Z, Panickar R, Kamarulzaman A. Mohd Sani N, et al. Among authors: aziz z. BioDrugs. 2022 Jul;36(4):489-508. doi: 10.1007/s40259-022-00541-x. Epub 2022 Jul 1. BioDrugs. 2022. PMID: 35776294

8

Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia.

Panickar R, Aziz Z, Kamarulzaman A. Panickar R, et al. Among authors: aziz z. BMC Public Health. 2022 Jul 5;22(1):1293. doi: 10.1186/s12889-022-13703-x. BMC Public Health. 2022. PMID: 35788213 Free PMC article.

9

Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey.

Mohd Sani N, Aziz Z, Kamarulzaman A. Mohd Sani N, et al. Among authors: aziz z. BioDrugs. 2023 Jan;37(1):109-120. doi: 10.1007/s40259-022-00571-5. Epub 2022 Dec 26. BioDrugs. 2023. PMID: 36571697 Free PMC article.

10

The use of technology in vaccine safety communication: A systematic review of randomised controlled trials.

Panickar R, Aziz Z, Mohd Sani N, Kamarulzaman A. Panickar R, et al. Among authors: aziz z. Patient Educ Couns. 2023 Jul;112:107707. doi: 10.1016/j.pec.2023.107707. Epub 2023 Mar 17. Patient Educ Couns. 2023. PMID: 36989861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters